Bill Snyder

July 2, 2019

Former Pharmacology chair Hardman remembered as gifted scientist, educator, mentor

Joel Hardman, PhD, an internationally recognized scientist and educator who chaired the Department of Pharmacology at Vanderbilt University School of Medicine from 1975 to 1990, died June 30, 2019 in Hoosick Falls, New York, after a lengthy illness. He was 85.

By Bill Snyder
Wendy Lloyd
June 26, 2019

Wendy Lloyd receives SoCRA recognition award

Wendy Lloyd, BA, LPN, CCRP, recognized by the Society of Clinical Research Associates (SoCRA)

By Bill Snyder
David Morrison, MD, and colleagues are studying whether to implant an artificial intraocular lens or fit a contact lens over a baby’s cornea after cataract surgery.
June 26, 2019

Study explores treatment options for babies with cataracts

Cataracts are uncommon in babies but when they occur the cloudy lenses must be removed without delay or blindness may result.

By Bill Snyder
June 20, 2019

Awards honor profound impact of research staff

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 15th annual Research Staff Awards luncheon at the Kimpton Aertson Hotel in Nashville.

By Bill Snyder
June 19, 2019

Patients of surgeons with higher reports of unprofessional behaviors are more likely to suffer complications

Patients of surgeons with higher numbers of reports from co-workers about unprofessional behavior are significantly more likely to experience complications during or after their operations, researchers from Vanderbilt University Medical Center reported June 19.

By Bill Snyder
June 14, 2019

New method tested to block chikungunya infection

Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.

By Bill Snyder
June 12, 2019

Steroid binding to metabolic enzyme

Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer.
By Bill Snyder
June 6, 2019

VUMC joins international effort to speed vaccine development

VUMC has joined an international effort to streamline and accelerate development of vaccines and other treatments against a growing worldwide surge of deadly and debilitating viral infections.
By Bill Snyder
May 16, 2019

Flu’s “hidden target” may lead to universal vaccine: study

Researchers at Vanderbilt University Medical Center and the Scripps Research Institute have discovered a “hidden target” on the surface of the hypervariable influenza A virus that could lead to better ways to prevent and treat the flu.
By Bill Snyder
May 9, 2019

Browser gives glimpse into rapidly growing “All of Us” databank

The national “All of Us” Research Program, which aims to accelerate the prevention and treatment of illness by recruiting a million or more research participants, provided a glimpse this week into its rapidly growing databank with the beta launch of its publicly accessible Data Browser application.
By Bill Snyder
May 9, 2019

New trans-institutional program to focus on genetic variations, disease

A new program at Vanderbilt will help researchers determine more precisely how genetic variations contribute to disease and what potentially can be done to put them right.
By Bill Snyder
May 3, 2019

Researchers putting the brakes on lethal childhood cancer

Malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers. Although rare — about 20 to 25 new cases are diagnosed annually in the United States — there is no standard effective treatment for the disease, which is driven by loss of an anti-cancer protein called SNF5. The chances are very small that a child will survive a year after MRT diagnosis.
By Bill Snyder
1 … 47 48 49 50 51 … 115